Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004234

Options or other derivatives

  • PRESIDENT AND CEO acquired 164,380 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Torley Helen PRESIDENT AND CEO 2025-02-12 Grant or award · Performance Stock Units +24,957 71,810 D
Torley Helen PRESIDENT AND CEO 2025-02-12 Grant or award · Performance Stock Units +20,008 31,364 D
Torley Helen PRESIDENT AND CEO 2025-02-12 Grant or award · Performance Stock Unit +23,260 23,260 D
Torley Helen PRESIDENT AND CEO 2025-02-12 Grant or award · Performance Stock Units +96,155 96,155 D
Loading xslF345X05/form4-02142025_110239.xml…